ATOX1 and breast carcinoma: We found a strong correlation between high ATOX1 mRNA levels and reduced DSS for Normal-like (median DSS of 161 months for low ATOX1 vs. 64 months for high ATOX1, p = 0.005), Luminal A (171 vs. 91 months, p = 0.002) and Luminal B (158 vs. 67 months, p = 0.001) breast cancer subtypes.